WHO WE ARE
Harold M. Koenig, MD
Major Areas of Expertise:
- Executive management and oversight of the medical policies, programs and activities of the entire Department of the Navy
- Environmental health, safety and public healthcare policy
- Pediatric hematology
Summary of Career Accomplishments:
Harold Koenig became a Senior Partner with Martin, Blanck & Associates, Inc. in 1998. He retired in 1998 as the Surgeon General of the Navy and Chief, Bureau of Medicine and Surgery, with the permanent rank of Vice Admiral after a 32-year career in Navy medicine. As Surgeon General, Dr. Koenig exercised day-to-day executive management and oversight of the entire Department of the Navy's medical policies, programs and activities. Prior to serving as Navy Surgeon General, he was assigned to the Office of the Secretary of Defense, where he served as a Deputy Assistant Secretary of Defense (Health Affairs).
Additional Qualifications:
Dr. Koenig served four-year terms on advisory boards to the National Center for Environmental Health and the Agency for Toxic Substances and Disease Registry at the Center for Disease Control and Prevention (CDC). Dr. Koenig has served on the board of directors of three San Diego-based companies with activities in the healthcare sector. In September 2007, he completed a term as president of the Society of Medical Consultants to the Armed Forces.
Dr. Koenig received a Bachelor of Science from Brigham Young University in Provo, Utah and a Doctor of Medicine from Baylor University College of Medicine, Houston, Texas.
Martin, Blanck & Associates:
Martin, Blanck & Associates is a healthcare consulting firm based in Alexandria, Virginia. Martin Blanck provides critical assistance to private sector clients focused on federal healthcare delivery systems and services and public health programs. The firm has more than two dozen senior executive partners with expertise in healthcare policy, program development, executive management, strategic planning, informatics, medical countermeasures research and development addressing chemical, biological and radiological threats, public health strategies, and emerging infectious diseases.
